Formulation Development
FTF Pharma is a research-oriented company developing high-quality pharmaceutical products in both generics and innovative finished formulations. We develop new generic molecules every year, together with innovative formulation projects based on drug-delivery technologies.
Our formulation scientists combine galenical expertise with patent understanding and pharmacokinetic insight - helping generic and brand companies establish new technology platforms and differentiated products.
Dosage forms we develop
Oral Solid Dosage (OSD)
Tablets, capsules and multiparticulates - immediate, modified and extended release, including modified-release oral pellets, IR-to-SR conversion and new combination products. cGMP manufacturing support for scale-up and pilot BE batches.
Sterile Injectables
Liquid and lyophilized parenteral dosage forms, supported by an NDDS team with expertise in injectable product development.
Ophthalmic
Development of ophthalmic dosage forms from pre-formulation through scale-up.
Nasal
Development of nasal dosage forms, including permeation and absorption enhancement approaches.
Dermal
Topical and dermal dosage forms - supported by diffusion-cell and particle-size characterisation.
Patches
Development of transdermal and topical patch products.
High Potency
Development of high-potency products with appropriate containment and handling.
Content to be provided by FTF Pharma: confirm and expand the description for each dosage form (ophthalmic, nasal, patches and high potency in particular).
Formulation technologies
Liquid & lyophilized parenteral dosage forms
Topical dosage forms
Solubility & permeability enhancement technologies
Alternative pharmaceutical dosage forms
Modified-release oral pellet formulations
Development of IR to SR dosage forms
Development of new combination products
NDDS development
Our NDDS (New Drug Delivery Systems) department is supported by scientists with expertise in injectable product development.
New combinations
Metabolite development
505(b)(2) applications
Permeation / absorption enhancement
Generic-plus products
Identification of new products
The first and most critical step of any business process is selecting the best and most profitable product. Based on a large database and deep experience in the generic industry, FTF Pharma helps partners select products that best fit their portfolio and needs.
Scientific, legal and commercial analysis of products
Technological feasibility, competition analysis, cost of development and return-on-investment projections
Incremental innovation to work around the maze of patents and make the product niche
New dosage forms, new combinations and new drugs
Product differentiation and life-cycle management of high-value products